glp-1 drugs sleep apnea Episode 75- GLP 1 and 5 Benefits of GLP-1 Medications

Industry giants like Pfizer, Novo Nordisk, and Eli Lilly dominate, offering a broad portfolio that includes GLP-1 receptor agonists and other advanced therapeutics

An observational cohort study involving 168 pregnant women exposed to GLP-1 receptor agonists during the first trimester found a 2.6% prevalence of major birth defects, comparable to 2.3% in the diabetic reference group

Roche's enicepatide is in Phase 3 with Phase 2 data at 22.5% placebo-adjusted weight loss

All loans subject to credit approval

However, when weight regain occurs despite these hormonal changes, pharmacological augmentation with GLP-1 receptor agonists may help restore the metabolic advantages